PubRank

I Frank

Author PubWeight™ 63.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994 2.82
2 Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med 1992 2.71
3 Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 1996 2.36
4 Screening surgeons for HIV infection: assessment of a potential public health program. Infect Control Hosp Epidemiol 1994 2.03
5 Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994 1.88
6 Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study. Clin Infect Dis 2008 1.81
7 Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995 1.74
8 Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 1991 1.73
9 Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J Infect Dis 1990 1.69
10 Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. J Infect Dis 1999 1.67
11 Surgical treatment of abdominal aortic aneurysms. Surgery 1968 1.63
12 Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J Virol 1990 1.38
13 An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). J Infect Dis 2011 1.37
14 Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol 1999 1.26
15 Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. J Clin Invest 1992 1.20
16 Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 1997 1.17
17 Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Clin Microbiol Infect 2011 1.15
18 IL-15 enhances immune functions during HIV infection. J Immunol 1997 1.13
19 Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994 1.13
20 Poisoning from ingestion of a stramonium-belladonna mixture: flower power gone sour. JAMA 1968 1.12
21 Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate. Antimicrob Agents Chemother 1986 1.11
22 Proliferation of primary sensory neurons in adult rat dorsal root ganglion and the kinetics of retrograde cell loss after sciatic nerve section. Somatosens Res 1985 1.07
23 Treatment of cryptosporidiosis with paromomycin. A report of five cases. Arch Intern Med 1992 1.03
24 Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993 1.02
25 Application of transtracheal pressure oscillations as a modification of "diffusing respiration". Br J Anaesth 1972 1.00
26 Nurse practitioner managed care for persons with HIV infection. Image J Nurs Sch 1993 0.98
27 Interaction of terbinafine with human serum and serum proteins. J Med Vet Mycol 1992 0.97
28 Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J Clin Invest 1995 0.93
29 Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease. J Clin Invest 1997 0.90
30 [Autoantibody detection by indirect immunofluorescence on HEp-2 cells]. Dtsch Med Wochenschr 2009 0.89
31 Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. AJNR Am J Neuroradiol 1994 0.87
32 Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients. Br J Ophthalmol 1989 0.86
33 The keratinocyte-derived cytokine IL-7 increases adhesion of the epidermal T cell subset to the skin basement membrane protein laminin-5. Eur J Immunol 1999 0.86
34 Prototheca zopfii isolated from a patient with olecranon bursitis. Diagn Microbiol Infect Dis 1987 0.85
35 Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1996 0.85
36 Complications and initial continence rates after a repeat pubovaginal sling procedure for recurrent stress urinary incontinence. J Urol 2001 0.85
37 Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.85
38 Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med 1994 0.85
39 Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J Virol 1998 0.84
40 Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers. HIV Med 2007 0.83
41 Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. J Viral Hepat 2013 0.83
42 Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol Immunol 1998 0.83
43 Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18. Eur J Microbiol Immunol (Bp) 2012 0.81
44 The envelope of HIV. Immunol Lett 1996 0.81
45 Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. Clin Diagn Lab Immunol 1999 0.81
46 [Intrapulmonary gas exchange during simulated apnea due to transtracheal periodic intrathoracic pressure changes]. Anaesthesist 1973 0.80
47 Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency. AIDS Res Hum Retroviruses 2005 0.79
48 Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro. AIDS Res Hum Retroviruses 2000 0.79
49 Interleukin-12 in the pathogenesis and therapy of HIV disease. Res Immunol 1996 0.79
50 Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder. Urology 1991 0.78
51 Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1). Viral Immunol 1992 0.78
52 [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus]. Z Gesamte Inn Med 1986 0.78
53 A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.77
54 Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. Clin Infect Dis 1995 0.77
55 Light- and electron microscopic investigations of pulmonary tissue after high-frequency positive-pressure ventilation (HFPPV). Anaesthesist 1975 0.77
56 Interleukin-2 treatment of microglia has no effect on in vitro HIV infection. AIDS 1999 0.76
57 [Test measuring myocardial consistency using transtracheally excited oscillation of the heart caused by pressure changes. I]. Arch Kreislaufforsch 1972 0.75
58 The management of the academic under-achiever. Psychosomatics 1970 0.75
59 Iris Frank, administrator, pioneers innovative specialty hospital. Interview by Marlene Jezierski. J Emerg Nurs 1996 0.75
60 Effect of interleukin-12 on the cytokine profile of human CD4 and CD8 T-cell clones. Ann N Y Acad Sci 1996 0.75
61 [The modification of the effects of calcium on the heart using beta-adrenergic blockers]. Dtsch Tierarztl Wochenschr 1996 0.75
62 [New items in our laboratory]. Zahntechnik (Berl) 1976 0.75
63 Comprehensive approach in rural family practice. GP 1967 0.75
64 Australian Medical Council: a view from the inside. Intern Med J 2001 0.75
65 [Longterm therapy with anticoagulants]. Z Arztl Fortbild (Jena) 1966 0.75
66 [Delayed effects of calcium]. Dtsch Tierarztl Wochenschr 1994 0.75
67 Chromophore localization in conjugated polymers: molecular dynamics simulation. J Phys Chem B 2007 0.75
68 [Relaxation-promoting effect of vitamin B with anabolics]. Arzneimittelforschung 1970 0.75
69 Large perilymph fistulas. Am J Otol 1986 0.75
70 Two-year experience with electro-convulsive therapy in a semi-rural hospital. IMJ Ill Med J 1969 0.75
71 An analysis of the opinions toward mental health among nurses and physicians in Dekalb County, Illinois. IMJ Ill Med J 1966 0.75
72 [Laudation on bestowing of the Hippocrates Medal for Merits in general medicine to E. V. Kuenssberg, M.D. in Igls, 1974]. Z Allgemeinmed 1974 0.75
73 Teach me to fish. J Emerg Nurs 1985 0.75
74 Enhancement of CO2-elimination by intrapulmonary high frequency pressure alternation during "apnoeic oxygenation". Adv Exp Med Biol 1978 0.75
75 [Method of trans-tracheal vibration for the induction of periodic intra-ventricular pressure oscillations]. Pflugers Arch 1972 0.75
76 [Radioimmunologic determination of serum insulin: experiences with paper-wick chromatography]. Endokrinologie 1972 0.75
77 Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization. AIDS Care 2007 0.75
78 [Secretion of insulin before and after elimination of Dumping symptoms through transformation surgery]. Dtsch Z Verdau Stoffwechselkr 1974 0.75
79 [Dosage and duration of the streptokinase treatment in myocardial infarct. Preliminary report]. Folia Haematol Int Mag Klin Morphol Blutforsch 1969 0.75
80 Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene. FEBS Lett 1986 0.75
81 The necessity for new colleague relationships between professionals. IMJ Ill Med J 1975 0.75
82 Interpretation of the amplitude modulation profile following trans-tracheally induced intra-ventricular pressure oscillations. Pflugers Arch 1972 0.75
83 [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels]. Endokrinologie 1969 0.75
84 The management of adolescent crises in family practice. Adolescence 1975 0.75
85 Problems of sexuality as encountered in a general family practice. Psychosomatics 1974 0.75
86 [Transtracheally-induced intraventricular periodic pressure variations: a new diagnostic technic in cardiology]. Verh Dtsch Ges Kreislaufforsch 1972 0.75
87 Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients. Am J Med 1992 0.75
88 [Acid-base equilibirium and blood circulation following diffusion breathing under optimal vibration]. Pflugers Arch 1972 0.75